Skip to main content
SpringerLink
Log in

Ranbaxy agrees to pay $500 million drug safety settlement

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • The United States Department of Justice. Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA. Media Release : 13 May 2013. Available from: URL: http://www.justic.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ranbaxy agrees to pay $500 million drug safety settlement. Reactions Weekly 1453, 4 (2013). https://doi.org/10.1007/s40278-013-3239-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-3239-y

Search

Navigation